Role of ANG II in coronary capillary angiogenesis at the insulin-resistant stage of a NIDDM rat model

With the use of Otsuka Long-Evans Tokushima Fatty (OLETF) rats, a model of human non-insulin-dependent diabetes mellitus (NIDDM), we assessed whether ANG II is involved in coronary capillary angiogenesis at the insulin-resistant stage of NIDDM (20 wk of age). In OLETF rats, ANG II labeling and angiotensin type 1 (A[T.sub.1]) receptor expression in coronary vessels were increased more than in nondiabetic controls. A marked increase in vascular expression of vascular endothelial growth factor (VEGF) at both mRNA and protein levels was found in OLETF rats. The increased expression level of VEGF was associated with accumulation of hypoxia-inducible factor-1[alpha] (HIF-1[alpha]) activated by increased advanced glycation end products (AGEs). Morphometric analysis showed a significantly increased total coronary capillary density, which was a result of arterialization of the venular capillary portion in OLETF rats. Treatment of OLETF rats with candesartan, an A[T.sub.1] receptor blocker, inhibited vascular expressions of VEGF, HIF-1[alpha], and AGEs, and ameliorated the morphometric changes. These results suggest a key role of ANG II in the pathogenesis of the coronary capillary remodeling in this NIDDM model. vascular endothelial growth factor; hypoxia-inducible factor-1[alpha]; advanced glycation end products; coronary capillary remodeling; angiotensin II; non-insulin-dependent diabetes mellitus